1. A Quick Reminder That Bill Ackman's Worst Nightmare is Still Very Much a Thing

    A Quick Reminder That Bill Ackman's Worst Nightmare is Still Very Much a Thing

    It's time to check in on a Wall Street disaster.

    Valeant Pharmaceuticals will report earnings on February 28, and analysts up and down Wall Street remain skeptical that the company can get back on its feet after a nightmarish run.

    Here's what Wells Fargo analyst David Maris wrote about it in a recent note...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned

  3. Authors